Report Detail

Request for Sample of this report

Pharma & Healthcare Global Biologic Medication in COVID-19 Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4514142
    • |
  • 19 February, 2023
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to China's clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.
According to our (Global Info Research) latest study, the global Biologic Medication in COVID-19 market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biologic Medication in COVID-19 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biologic Medication in COVID-19 market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biologic Medication in COVID-19 market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologic Medication in COVID-19
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologic Medication in COVID-19 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Sanofi, Novartis, Merck and Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biologic Medication in COVID-19 market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Neutralizing Antibodies
Anti-inflammatory Drugs
Market segment by Application
COVID-19
Influenza
Malaria
Others
Market segment by players, this report covers
Roche
Sanofi
Novartis
Merck
Bayer
Shutaishen
Biogen
Regeneron Pharmaceuticals
Vir Biotech
Junshi Biosciences
Anke Biotechnology
OncoImmune
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biologic Medication in COVID-19 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologic Medication in COVID-19, with revenue, gross margin and global market share of Biologic Medication in COVID-19 from 2018 to 2023.
Chapter 3, the Biologic Medication in COVID-19 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biologic Medication in COVID-19 market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Medication in COVID-19.
Chapter 13, to describe Biologic Medication in COVID-19 research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Biologic Medication in COVID-19
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biologic Medication in COVID-19 by Type
    • 1.3.1 Overview: Global Biologic Medication in COVID-19 Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Biologic Medication in COVID-19 Consumption Value Market Share by Type in 2022
    • 1.3.3 Neutralizing Antibodies
    • 1.3.4 Anti-inflammatory Drugs
  • 1.4 Global Biologic Medication in COVID-19 Market by Application
    • 1.4.1 Overview: Global Biologic Medication in COVID-19 Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 COVID-19
    • 1.4.3 Influenza
    • 1.4.4 Malaria
    • 1.4.5 Others
  • 1.5 Global Biologic Medication in COVID-19 Market Size & Forecast
  • 1.6 Global Biologic Medication in COVID-19 Market Size and Forecast by Region
    • 1.6.1 Global Biologic Medication in COVID-19 Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Biologic Medication in COVID-19 Market Size by Region, (2018-2029)
    • 1.6.3 North America Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
    • 1.6.6 South America Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Biologic Medication in COVID-19 Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Biologic Medication in COVID-19 Product and Solutions
    • 2.1.4 Roche Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Biologic Medication in COVID-19 Product and Solutions
    • 2.2.4 Sanofi Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Sanofi Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Biologic Medication in COVID-19 Product and Solutions
    • 2.3.4 Novartis Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Merck
    • 2.4.1 Merck Details
    • 2.4.2 Merck Major Business
    • 2.4.3 Merck Biologic Medication in COVID-19 Product and Solutions
    • 2.4.4 Merck Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Merck Recent Developments and Future Plans
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer Biologic Medication in COVID-19 Product and Solutions
    • 2.5.4 Bayer Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Bayer Recent Developments and Future Plans
  • 2.6 Shutaishen
    • 2.6.1 Shutaishen Details
    • 2.6.2 Shutaishen Major Business
    • 2.6.3 Shutaishen Biologic Medication in COVID-19 Product and Solutions
    • 2.6.4 Shutaishen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Shutaishen Recent Developments and Future Plans
  • 2.7 Biogen
    • 2.7.1 Biogen Details
    • 2.7.2 Biogen Major Business
    • 2.7.3 Biogen Biologic Medication in COVID-19 Product and Solutions
    • 2.7.4 Biogen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Biogen Recent Developments and Future Plans
  • 2.8 Regeneron Pharmaceuticals
    • 2.8.1 Regeneron Pharmaceuticals Details
    • 2.8.2 Regeneron Pharmaceuticals Major Business
    • 2.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product and Solutions
    • 2.8.4 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
  • 2.9 Vir Biotech
    • 2.9.1 Vir Biotech Details
    • 2.9.2 Vir Biotech Major Business
    • 2.9.3 Vir Biotech Biologic Medication in COVID-19 Product and Solutions
    • 2.9.4 Vir Biotech Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Vir Biotech Recent Developments and Future Plans
  • 2.10 Junshi Biosciences
    • 2.10.1 Junshi Biosciences Details
    • 2.10.2 Junshi Biosciences Major Business
    • 2.10.3 Junshi Biosciences Biologic Medication in COVID-19 Product and Solutions
    • 2.10.4 Junshi Biosciences Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Junshi Biosciences Recent Developments and Future Plans
  • 2.11 Anke Biotechnology
    • 2.11.1 Anke Biotechnology Details
    • 2.11.2 Anke Biotechnology Major Business
    • 2.11.3 Anke Biotechnology Biologic Medication in COVID-19 Product and Solutions
    • 2.11.4 Anke Biotechnology Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Anke Biotechnology Recent Developments and Future Plans
  • 2.12 OncoImmune
    • 2.12.1 OncoImmune Details
    • 2.12.2 OncoImmune Major Business
    • 2.12.3 OncoImmune Biologic Medication in COVID-19 Product and Solutions
    • 2.12.4 OncoImmune Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 OncoImmune Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biologic Medication in COVID-19 Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Biologic Medication in COVID-19 by Company Revenue
    • 3.2.2 Top 3 Biologic Medication in COVID-19 Players Market Share in 2022
    • 3.2.3 Top 6 Biologic Medication in COVID-19 Players Market Share in 2022
  • 3.3 Biologic Medication in COVID-19 Market: Overall Company Footprint Analysis
    • 3.3.1 Biologic Medication in COVID-19 Market: Region Footprint
    • 3.3.2 Biologic Medication in COVID-19 Market: Company Product Type Footprint
    • 3.3.3 Biologic Medication in COVID-19 Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biologic Medication in COVID-19 Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Biologic Medication in COVID-19 Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Biologic Medication in COVID-19 Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Biologic Medication in COVID-19 Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
  • 6.2 North America Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
  • 6.3 North America Biologic Medication in COVID-19 Market Size by Country
    • 6.3.1 North America Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
    • 6.3.2 United States Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
  • 7.2 Europe Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
  • 7.3 Europe Biologic Medication in COVID-19 Market Size by Country
    • 7.3.1 Europe Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 7.3.3 France Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region
    • 8.3.1 Asia-Pacific Biologic Medication in COVID-19 Consumption Value by Region (2018-2029)
    • 8.3.2 China Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 8.3.5 India Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
  • 9.2 South America Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
  • 9.3 South America Biologic Medication in COVID-19 Market Size by Country
    • 9.3.1 South America Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country
    • 10.3.1 Middle East & Africa Biologic Medication in COVID-19 Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Biologic Medication in COVID-19 Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Biologic Medication in COVID-19 Market Drivers
  • 11.2 Biologic Medication in COVID-19 Market Restraints
  • 11.3 Biologic Medication in COVID-19 Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Biologic Medication in COVID-19 Industry Chain
  • 12.2 Biologic Medication in COVID-19 Upstream Analysis
  • 12.3 Biologic Medication in COVID-19 Midstream Analysis
  • 12.4 Biologic Medication in COVID-19 Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biologic Medication in COVID-19. Industry analysis & Market Report on Biologic Medication in COVID-19 is a syndicated market report, published as Global Biologic Medication in COVID-19 Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Biologic Medication in COVID-19 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,198.12
    		4,797.18
    		6,396.24
    		529,203.60
    		793,805.40
    		1,058,407.20
    		292,876.80
    		439,315.20
    		585,753.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo